GIL-DDI: Multi-View Graph Invariant Learning for Unknown Drug-Drug Interaction Prediction

Read the full article See related articles

Listed in

This article is not in any list yet, why not save it to one of your lists.
Log in to save this article

Abstract

Drug-Drug Interaction (DDI) prediction is essential for evaluating the side effects of a new drug and adverse interactions before the clinical application.The latest research applies multi-view data to enhance the generalization ability of models to predict new drug interactions, mainly unknown Drug-Drug Interaction (uDDI).However, a new drug's feature inevitably encounters the feature-shift problem; the trained models have not previously learned information about the new drug, significantly decreasing the uDDI prediction's accuracy.Thus, we proposed the GIL-DDI model that tries to extract the invariant features of known drugs, alleviating the impact of the feature-shift problem on the prediction of uDDI.In detail, the graph attention network(GAT) models embed multi-view drug graphs, including drug-chemical entities, drug substructures, drug-drug interactions, and molecular structures. Then, invariant features corresponding to the new drug are learned from the knowledge graph of the previous drugs.After that, a variant feature of the new drug is embedded through the GAT models and fused with learned invariant drug features to predict the DDI.Extensive experiments on real-world drug datasets indicate that the proposed method achieves new state-of-the-art records on new drug DDI prediction tasks. The source code is available at https://anonymous.4open.science/r/GIL-DDI-F701/README.md.

Article activity feed